Beyond BYON 深 沪
已收盘 08-28 16:00:00 美东时间
9.44
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 9.44
- 总市值 5.42亿
- 52周最高 12.24
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 3.54
- 委 比 0.00%
- 总股本 5740.60万
- 历史最高 37.10
- 量 比 0
- 振 幅 0.00%
- 历史最低 3.54
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Village Farms Applauds Budget 2026 Common Cannabis Excise Stamp
Village Farms International welcomed Canada's announcement in Budget 2026 of a common cannabis excise duty stamp, reducing the number of stamps from 13 to six. The measure, which takes effect January 1, 2028, aims to simplify the supply chain and reduce costs. The company praised the government for addressing a longstanding regulatory burden and urged all provinces and territories to adopt the national stamp. Canada's legal cannabis industry cont...
11-06 12:00
VisionWave Targets Dual-Use Expansion Across Defense, Infrastructure, Agriculture and Aviation Markets
VisionWave Holdings, Inc. is advancing a dual-use technology strategy to extend defense-developed autonomous platforms, AI, and sensing technologies into commercial markets such as infrastructure maintenance, agriculture, aviation, and industrial automation. The company's approach leverages a shared technology architecture to support multiple applications through mission-specific modules. Key initiatives include the Solar Drone system for aerial ...
11-05 12:00
Beyond Meat Q3 2026 Earnings Call Transcript
Beyond Meat (NASDAQ:BYND) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.co...
11-05 07:12
Syndax Highlights Acceptance of 19 Revuforj® (revumenib) and Niktimvo™ (axatilimab-csfr) Abstracts, Including 7 for Oral Presentation, at ASH 2026
Syndax Pharmaceuticals announced the acceptance of multiple abstracts for presentation at the 68th ASH Annual Meeting, including 14 for revumenib (7 oral presentations) and 5 for axatilimab. Revumenib data highlight encouraging activity across acute leukemia subtypes,前线治疗, 移植后维持治疗, and MRD复发. Real-world data also demonstrate compelling results in R/R NPM1m or KMT2Ar急性白血病患者. Axatilimab的长期数据展示了其在R/R cGVHD中的潜在临床获益. Syndax will host an investor event...
11-04 14:00
AMD Stock Forecast: $17 Billion Outlook Brings $511.74 Recovery Test Into Focus
TradingKey - AMD’s $17 billion revenue outlook lifts shares into a key resistance zone. Explore Helios delivery risks, cash flow and the $511.74 recovery test.
11-04 12:00
ESGold Advances Montauban Drilling Beyond Historic Mine
The latest announcement is out from Secova Metals ( ($TSE:ESAU) ). ESGold Corp....
11-04 00:33
Atlanticus to Participate in KBW Fintech Ecosystem Conference
Atlanticus Holdings Corporation (NASDAQ: ATLC), a fintech company enabling partners to offer inclusive financial services, announced that CEO Jeff Howard and CFO Bill McCamey will attend the KBW Fintech Ecosystem Conference in New York on November 10-12, 2026. Jeff Howard will participate in a fireside chat titled “Beyond the Credit Score: Expanding Access without Buying Losses” on November 12 at 12:25pm. Additional conference details are availab...
11-03 21:01
Kaltura Selected by Israel’s Ministry of Education to Power Personalized AI Learning in K–12 Schools
Kaltura's Agentic Learning & Enablement platform is being used in Israel's 720 initiative to advance personalized STEM learning in K-12 schools. The pilot program, involving 20 schools and 2,000 students, combines conversational AI avatar tutors, interactive practice, and teacher insights. The platform supports personalized learning paths, real-time guidance, and progress tracking, with plans to expand to additional subjects and countries. Kaltur...
11-03 13:00
Parabilis Medicines to Participate in Upcoming November Investor Conferences
Parabilis Medicines (PBLS) announced that its leadership team will participate in three investor conferences in November 2026: the Guggenheim Healthcare Innovation Conference in Boston, the Jefferies Global Healthcare Conference in London, and the Evercore ISI Annual Healthcare Conference in Miami. Live webcasts and replays of these events will be available on the company's investor website. Parabilis focuses on developing medicines for serious d...
11-03 12:00
ECT Expands MXene Commercialisation Rights Beyond Defence
Environmental Clean Technologies Limited ( ($AU:ECT) ) has issued an announceme...
11-02 06:47
